Mitchell Chan | Chief Financial Officer |
Bing Yao | Chairman and Chief Executive Officer |
Jorn Drappa | Chief Medical Officer, Head of Research and Development |
Bill Ragatz | Vice President, Head of Commercial |
Seamus Fernandez | Guggenheim Securities, LLC |
Jeff Hung | Morgan Stanley |
Paul Choi | Goldman Sachs |
Chris Shibutani | Cowen and Company |
Raghuram Selvaraju | H.C. Wainwright & Co. |
Good afternoon, ladies and gentlemen, and welcome to the Viela Bio Fourth Quarter and Full-Year 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session and instructions will be given at that time.
As a reminder, this conference call is being recorded.
I would now like to hand the call over to Mr.